Kukko, Ville http://orcid.org/0000-0001-9584-8693
Kaipia, Antti
Talala, Kirsi
Taari, Kimmo
Tammela, Teuvo L. J.
Auvinen, Anssi
Murtola, Teemu J.
Funding for this research was provided by:
Academy of Finland (312330724)
Pirkanmaan Sairaanhoitopiiri (9AC059)
Article History
Received: 4 April 2022
Revised: 20 August 2022
Accepted: 5 September 2022
First Online: 21 September 2022
Competing interests
: TLJT: consultant fees from Astellas, Bayer and Roche. TJM: consultant fees from Novartis, Astellas, Janssen Cilag, Amgen and Recordati. Lecture fees from Ferring, Novartis, Sanofi, Bayer, Roche, Pfizer, Ipsen, Astellas, Amgen and Janssen Cilag. Research funding from Bayer. KTaari: Research funding from Medivation/Astellas/Pfizer, Orion, Myovant. Other authors declare no conflict of interests.